Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model

Cancer Research

Volumn 61, Issue 2, 2001, Pages 532-537

  Frandsen, Thomas Leth ^a   Holst Hansen, Claus ^a   Nielsen, Boye Schnack ^a   Christensen, Ib Jarle ^a   Nyengaard, Jens R ^a,b   Carmeliet, Peter ^c   Brünner, Nils ^a  

^a FINSEN LABORATORY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INVASION; CANCER MODEL; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; GENE DISRUPTION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG METASTASIS; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STROMA; TUMOR VOLUME; XENOGRAFT;

ANIMALS; ANTIGENS, CD34; BREAST NEOPLASMS; CELL DIVISION; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOTYPE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, MUTANT STRAINS; MICE, NUDE; MICE, SCID; MUTATION; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; STROMAL CELLS; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED; URINARY PLASMINOGEN ACTIVATOR;

EID: 0035863308     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
2. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma
3. Expression of uPA and its receptor by both neoplastic and stromal cells during xenograft invasion
4. Antibodies to plasminogen activator inhibit human tumor metastasis
5. Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
6. Inhibition of urokinase-type plasminogen activator by antibodies: The effect on dissemination of a human tumor in the nude mouse
7. Antisense inhibition of urokinase reduces spread of human ovarian cancer in mice
8. Urokinase-type plasminogen activation in three human breast cancer cell lines correlates with their in vitro invasiveness
9. Requirement for receptor-bound urokinase in plasmin-dependent cellular conversion of latent TGF-β to TGF-β
10. In vivo angiogenic activity of urokinase: Role of endogenous fibroblast growth factor-2
11. Mitogenic effect of urokinase on malignant and unaffected adjacent human renal cells
12. Urokinase-type and tissue-type plasminogen activators as growth factors of human fibroblasts
13. Urokinase- And tissue-type plasminogen activators in keratinocytes during wound repepithelialization
14. Plasminogen activation by human keratinocytes: Molecular pathways and cell-biological consequences
15. Urokinase is a positive regulator of epidermal proliferation in vivo
16. Chemotactic effect of urokinase plasminogen activator: A major role for mechanisms independent of its proteolytic or growth factor domains
17. Physiological consequences of loss of plasminogen activator gene function in mice
18. Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice
19. Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes
20. Temporal and topographic matrix metalloproteinase expression after vascular injury in mice
21. Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator
22. Induction of primary cutaneous melanocytic neoplasms in urokinase-type plasminogen activator (uPA)-deficient and wild-type micecellular blue nevi invade but do not progress to malignant melanoma in uPA-deficient animals
23. lacZ transduced human breast cancer xenografts as an in vivo model for the study of invasion and metastasis
24. Two alternatively spliced mouse urokinase receptor mRNAs with different histological localization in the gastrointestinal tract
25. Improved medium for extraction of plasminogen activator from tissue
26. Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 workshop
27. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
28. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA
29. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity
30. A new immunocapture assay for Escherichia coli β-galactosidase for in vivo studies of lacZ-transduced tumor cells
31. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
32. Plasma Escherichia coli β-galactosidase as a marker of tumor burden and response to experimental anti-neoplastic therapy in nude mice xenografted with lacZ transduced human tumor cells
33. Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor
34. A cleaved form of the receptor for urokinase-type plasminogen activator in invasive transplanted human and murine tumors
35. Upregulation of cell-surface-associated plasminogen activation in cultured keratinocytes by interleukin-1-β and tumor necrosis factor-α
36. Urokinase receptor antagonists: Discovery and application to in vivo models of tumor growth
37. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice
38. Upregulation of urokinase receptor expression on migrating endothelial cells
39. Urokinase-type plasminogen activator is induced in migrating capillary endothelial cells
40. Adenovirus-mediated delivery of a uPA/uPAR antagonist suppresses angiogenesis-dependent tumor growth and dissemination in mice